Not in force
397. A professional authorized to prescribe medications must, to use a medication which may be provided subject to the conditions set out in section 396, obtain a written authorization from the institution’s pharmacology committee. The committee may not grant its authorization if the Institut national d’excellence en santé et en services sociaux has, in a notice to the Minister, refused to recognize the therapeutic value of the medication for the therapeutic indication for which the application for authorization is made.
The professional must set out in writing both the medication’s favourable efficacy potential and the other reasons for the application. The professional must submit the scientific data in support of the application showing that the medication the professional wishes to use will effectively meet the user’s particular needs.
The pharmacology committee renders a decision in writing, with reasons.
2023, c. 342023, c. 34, s. 397.